SOLVENT BASED ADHESSIVES

Properties ADCOTE™ 548-81R+COREACTANT F BOSTIK HP8660/

ADCOTE 548-81R COREACTANT F HP8660
OH-component NCO-component OH-component
solid content(%) 66 75 67±2
viscosity (mPas at 25C) 4500 +- 1500 1800 +- 500 5,000 ~ 8,000

Density (g/cm3) 1.05 1.17

solvents methyl ethyl ketone ethyl acetate EA
mix ratio 100 11 100
appearance liq,clear,colorless to amber liq,transparent,light amber good
Coating Weight 2-5 g/m2 3.5 ~ 4.0 gsm
Curing Condition 5-10 days 50C * 96 hours
Performance intermediate medium-high
Tunnel settings 55oC, 70oC, 85oC 55oC, 70oC, 85oC
Drying temp. range 60-100°C
Pot Life 8 hours at 35% of solids content. long and stable

boil-in-bag, aggressive materials(tomato concentrates), soaps,

applications Hair conditioner,
cosmetics,printing inks, films, additives, coatings

Compositionally compliant, with limitation, with FDA, 21 CFR

Food legislations 175.105, European and local food legislations
BOSTIK HP8660/KN75 BOSTIK LG61 / CAT Y BOSTIK EPS6560/KN75
KN75 LG61 CAT Y EPS6560 KN75
NCO-component OH-component NCO-component OH-component NCO-component
75±2 75±2 100 60±2 75
1,000 ~ 3,000 2,000 ~ 5,000 300 ~ 900 500 ~ 1,500 1,000 ~ 3,000

EA EA None EA EA
10 100 10 100 10 ~ 14

3.5 ~ 4.0 gsm 2.7 ~ 3.0 gsm 3.5 ~ 4.0 gsm

50C * 96 hours 28 ~ 35C * 24 hours 50C * 96 hours
medium-high fast-curing high
55oC, 70oC, 85oC 55oC, 70oC, 85oC 55oC, 70oC, 85oC

long and stable long and stable long and stable

Hair conditioner,

many international
food contact regulations
 BOSTIK HP 8660/KN75
HP 8660 KN75
OH-component NCO-component
67+-2 75+-2
5000-8000 1000-3000

EA EA
100 10

2 gsm(dry), 3gsm(optimum)
7 to 10 days
Verified by Testing
55oC, 70oC, 85oC
Depend on caoting weight
24 hours at ambient temperature

production of laminates, paper and

cardboard, plastic films and
aluminium

Recommendations of the German Health

Dept. (BfR), chapter XXVIII,
The EEC-directive 2002/72 and
amendments (including
90/128/EC) the Council of Europe's
resolution AP (96) 5 and amendment,
- CFR, title 21, § 175.105 of the FDA,
Washington D.C.,